Press release
Alzheimer’s Disease Diagnostic Market is Predicted to Reach USD 12 billion by 2022
As per Market Research Future (MRFR) analysis, the global Alzheimer’s disease diagnostic market is estimated to reach USD 12 billion with a CAGR of 10% from 2016 to 2022 (forecast period).
Alzheimer's is a kind of dementia that results in memory loss combined with thinking and behavioral problems. Alzheimer's is a progressive disease as it grows gradually over time and damages the maximum part of the brain that finally destroys brain cells. Alzheimer's disease (AD) is the most common cause of progressive dementia in the elderly. There has been an unprecedented growth in the number of cases of Alzheimer's disease globally, highlighting the need for effective treatment. According to the Alzheimer's Association, an estimated 5.4 million Americans of all ages had Alzheimer's disease in 2016. One in nine people aged 65 and over has Alzheimer's disease. In 2050, the number of people aged 65 and over with Alzheimer's disease is projected to almost increase from 5.2 million to 13.8 million, without medical advancements to prevent or cure the disease. Mortality levels due to Alzheimer's disease are relatively high. Between 2000 and 2013, heart, stroke, and prostate cancer deaths decreased by 14%, 23%, and 11%, respectively, while AD deaths rose by 71% in the US. Likewise, according to Alzheimer's disease International, an estimated 46.8 million people worldwide were living with dementia in 2015 and are expected to rise in the future. As a result, the market for Alzheimer's Diagnostics is growing worldwide.
Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/2149
Alzheimer’s Disease Diagnostic Market Dynamics
Globally, the aging population is a primary factor of Alzheimer's disease diagnostics market. Rising life expectancy leads to a significant rise in the number of older people and is associated with an increase in the prevalence of chronic diseases such as dementia. Alzheimer's disease treatments provide temporary and uncertain improvements in the well-being of individuals, and none of the approved medications can change the progression of the disease. Therefore, the magnitude of the affected population and the lack of adequate and effective treatment presents an enormous opportunity for drug manufacturers. However, the identification of the primary reasons and mechanisms involved in Alzheimer's disease is minimal. Drug manufacturers have been unable to demonstrate substantial clinical benefits of treatment for various new compounds due to stringent regulations. The collaboration of emerging players is one of the significant trends observed in this market.
Alzheimer’s Disease Diagnostic Market Segmentation
The global market for Alzheimer’s disease diagnostic has been segmented into type, diagnostic tests, and end-users.
Based on type, the global market for Alzheimer’s disease diagnostic has been segmented into early-onset Alzheimer's disease, familial Alzheimer's disease, late-onset Alzheimer's disease, and more.
Based on diagnostic tests, the global market for Alzheimer’s disease diagnostic has been segmented into genetic testing, mini-mental state exam (MMSE), neurological exam, brain imaging, and others.
Based on end-users, the global market for Alzheimer’s disease diagnostic has been segmented into clinics, hospitals, diagnostic centers, and others.
Alzheimer’s Disease Diagnostic Market Regional Analysis
Region-wise, the global market for Alzheimer’s disease diagnostic has been segmented into North America, Europe, Asia Pacific and the Middle East & Africa.
North America had the highest market share in the global market for Alzheimer's disease diagnostic in 2015. Alzheimer's disease diagnostic market in North America is expected to hit USD 12 million by the end of the forecast period. The rise in the market is due to the increasing prevalence of Alzheimer's disease with an increase in the aging population and significant technological advancements in the field.
Europe is the second-largest market for Alzheimer's disease diagnostic.
The Asia Pacific is predicted to be the fastest-growing Alzheimer's disease diagnostic market.
Alzheimer’s Disease Diagnostic Market Key Players
Some of the key players identified by MRFR in this market are Eli Lilly and Company (UK), Alector LLC (US), TauRx (Republic of Singapore), Accera, Inc. (US), Neuro-Bio Ltd (UK), Treventis Corporation (US), Cognition Therapeutics Inc. (US) and others.
Ask Questions To The Experts @ https://www.marketresearchfuture.com/enquiry/2149
Table Of Content
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
...TOC Continued
List Of Tables
TABLE 1 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, 2013-2022 (USD MILLION)
TABLE 2 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY TYPE, 2013-2022 (USD MILLION)
TABLE 3 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY DIAGNOSTICS TYPE, 2013-2022 (USD MILLION)
TABLE 4 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY END USERS, 2013-2022 (USD MILLION)
TABLE 5 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY REGION, 2013-2022 (USD MILLION)
...Continued
List Of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 GLOBAL ORTHOPEDIC TRAUMA DEVICE SMARKET, BY TYPE
FIGURE 4 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY DIAGNOSTICS TYPE
FIGURE 5 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY END USERS
FIGURE 6 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY REGION
FIGURE 7 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET: COMPANY SHARE ANALYSIS, 2015 (%)
...Continued
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/alzheimers-disease-diagnostic-market-2149
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alzheimer’s Disease Diagnostic Market is Predicted to Reach USD 12 billion by 2022 here
News-ID: 2086819 • Views: …
More Releases from Market Research Future
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years.
Market Overview and Size
The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in…
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends.
Get Sample @ https://www.marketresearchfuture.com/sample_request/41217
Market Size and Growth
The global washable…
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and…
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview:
The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical…
More Releases for Alzheimer
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…
